Medical Illness and Schizophrenia
American Psychiatric Press Inc. (Verlag)
978-1-58562-106-4 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
The life expectancy of patients with schizophrenia is approximately 20% shorter than that of the general population. Lifestyle choices, effects of medications, poor self-care, barriers to treatmentAall contribute to medical problems that increase the severity of psychopathology, reduce quality of life, and lead to premature death in patients with schizophrenia.
Medical Illness and Schizophrenia examines the links between medical conditions and severe chronic mental illness, with a focus on -The need for better medical assessment and treatment to improve outcomes in patients with schizophrenia -Links between schizophrenia and conditions such as obesity, cardiovascular disease, diabetes, HIV and hepatitis C, endocrine-related disorders, and others -The association between therapy with certain antipsychotics and adverse health outcomes including hyperlipidemia, obesity, and diabetes mellitus -The importance of improving community health services to treat the dual problems of medical and mental illnesses in the schizophrenic population Developed to fill a critical gap in the literature, Medical Illness and Schizophrenia is an important volume for any clinician who encounters patients with chronic severe mental illness. In addition, it serves to underscore the need to provide integrated medical and psychiatric care to this vulnerable population.
Jonathan M. Meyer, M.D., is Assistant Professor of Psychiatry, University of California, San Diego, Department of Psychiatry; and Staff Psychiatrist, San Diego VA Medical Center. Henry A. Nasrallah, M.D., is Professor of Psychiatry, Neurology and Neuroscience and Associate Dean at the University of Cincinnati College of Medicine.
Issues surrounding medical care for individuals with schizophrenia: the challenge of dual neglect by patients and the system. Excessive mortality and morbidity associated with schizophrenia. Obesity in patients with schizophrenia. Cardiovascular illness and hyperlipidemia in patients with schizophrenia. Nicotine and tobacco use in schizophrenia. Glucose intolerance and diabetes in schizophrenia. HIV and hepatitis C in patients with schizophrenia. Medical health in aging persons with schizophrenia. Substance use disorders in schizophrenia. Neurological comorbidity and features in schizophrenia. Prolactin- and endocrine-related disorders in schizophrenia. Index.
| Erscheint lt. Verlag | 5.5.2003 |
|---|---|
| Zusatzinfo | index |
| Verlagsort | VA |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| ISBN-10 | 1-58562-106-4 / 1585621064 |
| ISBN-13 | 978-1-58562-106-4 / 9781585621064 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
